搜索结果

Search Results for " nos-in-3 "

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T73353	NOS-IN-3
	NOS-IN-3 是一个强效的、选择性的由 imidamide 衍生的NOS 抑制剂，对iNOS 的IC50值为20 µM。 NOS-IN-3 不抑制eNOS，几乎没有毒性，可用于研究治疗可诱导亚型涉及的疾病，如感染性休克。
T83625	iNOS-IN-14 3-bromo-1H-indazole-7-carbonitrile	NOS	Immunology/Inflammation
	iNOS-IN-14 (3-bromo-1H-indazole-7-carbonitrile) 是一种有效的一氧化氮合酶(NOS)抑制剂，抑制nNOS的NADPH氧化酶活性。
T82251	GW274150 dihydrochloride	NO Synthase	Immunology/Inflammation
	GW274150 (dihydrochloride) 是高效、选择性的 NADPH 依赖型人诱导型一氧化氮合成酶 (iNOS) (Kd=40 nM) 抑制剂，具有口服活性，同时对大鼠 (iNOS) 也有效。相较于人和大鼠的内皮一氧化氮合酶 (eNOS) 及神经元一氧化氮合酶 (nNOS)，其效力显著较低。GW274150 (dihydrochloride) 在急性肺损伤炎症模型中具有保护作用。
T37238	(±)19(20)-EpDPA
	EDHF (endothelium-derived hyperpolarizing factor) is an unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (nitric oxide) and COX-derived (prostacyclin) vasodilators. Cytochrome P450 (CYP450) metabolism of polyunsaturated fatty acids produces epoxides such as (±)14(15)-EpETrE which are prime candidates for the actual active mediator. However, the CYP450 metabolites of eicosapentaenoic acid and docosahexaenoic...
T37234	(±)14(15)-EpETE
	EDHF (endothelium-derived hyperpolarizing factor) is an unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (nitric oxide) and COX-derived (prostacyclin) vasodilators. Cytochrome P450 (CYP450) metabolism of polyunsaturated fatty acids, produces epoxides such as (±)14(15)-EpETrE which are prime candidates for the actual active mediator. However, the CYP450 metabolites of eicosapentaenoic acid and docosahexaenoi...
T37235	(±)16(17)-EpDPA (±)16,17-EpDPE,(±)16,17 EDP,(±)16,17-epoxy Docosapentaenoic Acid,(±)16,17-epoxy DPA,(±)16(17)-EpDPA
	EDHF (endothelium-derived hyperpolarizing factor) is an unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (nitric oxide) and COX-derived (prostacyclin) vasodilators.[1],[2]Cytochrome P450 (CYP450) metabolism of polyunsaturated fatty acids produces epoxides such as (±)14(15)-EET which are prime candidates for the actual active mediator.[3] However, the CYP450 metabolites of eicosapentaenoic acid and docosahex...
T75339	Methylene blue hydrate
	亚甲蓝（Basic Blue 9）水合物，作为鸟苷酸环化酶（sGC）、单胺氧化酶A（MAO-A）及NO合酶（NOS）的抑制剂，常用于医疗作为血管加压剂及染料。该化合物通过影响一氧化氮合成酶/鸟苷酸环化酶信号通路，能够减少脉冲前抑制，同时作为一种氧化还原循环化合物，具有穿透血脑屏障的能力，并作为Tau蛋白聚集的抑制剂，有助于缓解脑水肿、减轻小胶质细胞活化和神经炎症。